This session invites papers in population balance applications to particulate processes particularly as applied in the pharmaceutical industry. Authors from industry and academia are encouraged to submit papers discussing such applications in the drug substance (API) processes(e.g. crystallization, nanoparticles) or in the drug product processes (e.g. granulation, milling or attrition) including population balance models development and experimental verification.

Pharmaceuticals